Improving cancer treatment by targeting specific RNA molecules in obese patients
Targeting Small Nucleolar RNA Augments Immunotherapeutic Efficacy
This study is looking at how a tiny piece of RNA called SNORD46 influences the immune system in breast cancer patients who are also dealing with obesity, with the goal of finding better treatments that work well for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10852005 on NIH RePORTER |
What this research studies
This research investigates how a specific small nucleolar RNA (SNORD46) affects the immune response in breast cancer patients, particularly those who are obese. The study aims to understand the genetic mechanisms that link obesity to breast cancer progression and resistance to immunotherapy. By targeting SNORD46, the researchers hope to enhance the effectiveness of existing cancer treatments, making them more beneficial for patients with obesity-related breast cancer. The approach involves analyzing genetic data and immune responses to develop new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients who are also classified as obese.
Not a fit: Patients with breast cancer who are not obese may not benefit from the specific findings of this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy options for breast cancer patients who are obese.
How similar studies have performed: Previous research has shown promise in targeting noncoding RNAs for cancer treatment, suggesting potential success for this novel approach.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Lin, Chunru — University of Tx Md Anderson Can Ctr
- Study coordinator: Lin, Chunru
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.